Related Experiment Videos
IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus
The Journal of Rheumatology
|November 18, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The evolution of patient-reported safety concerns during the COVID-19 pandemic within a series of study questionnaires: a multi-method analysis.
International journal for quality in health care : journal of the International Society for Quality in Health Care·2025
Socioeconomic Deprivation Correlates With Incomplete Radiotherapy Treatment in Head and Neck Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Dental referrals for patients with diabetes: survey of barriers and enablers for medical and health professionals.
Australian dental journal·2023
Ethnic differences in complement system biomarkers and their association with metabolic health in men of Black African and White European ethnicity.
Clinical and experimental immunology·2023
Assessment of Dietary Intake in Three Cohorts of Advanced Age in Two Countries: Methodology Challenges.
The journal of nutrition, health & aging·2023
Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.
The Journal of rheumatology·2026
Remission rates of patients with axial spondyloarthritis in a tertiary care center.
The Journal of rheumatology·2026
Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.
The Journal of rheumatology·2026
Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.
The Journal of rheumatology·2026
Immune Checkpoint Inhibitor-Induced Pancreatitis.
United European gastroenterology journal·2026
Identification of human leukocyte antigen class I risk alleles and enriched T cell receptor groups in activated T cell pediatric acute liver failure.
Journal of pediatric gastroenterology and nutrition·2026
The synergistic impact of granulocytic myeloid-derived suppressor cells and innate lymphoid cells in systemic sclerosis.
Arthritis & rheumatology (Hoboken, N.J.)·2026